Eurobio Scientific Société anonyme (EPA:ALERS)

EPA:ALERS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.92	20.32	21.77	49.3	47.49	92.92
Short-Term Investments	0.42	0.35	1.29	39.73	38.44	9.47
Cash & Short-Term Investments	26.34	20.66	23.07	89.03	85.94	102.39
Cash Growth	-1.94%	-10.41%	-74.09%	3.60%	-16.07%	56.18%
Accounts Receivable	43.15	33.02	32.09	26.94	32.78	43.86
Other Receivables	4.25	3.54	3.97	3.74	6.09	8.32
Receivables	47.4	36.56	36.06	30.67	38.87	52.18
Inventory	45.55	28.63	26.92	21.45	21.65	16.29
Prepaid Expenses	2.66	2.34	1.31	1.01	0.57	0.47
Other Current Assets	2.19	2.11	1.18	1.39	1.53	2.27
Total Current Assets	126.57	91.58	89.59	143.91	148.69	173.6
Property, Plant & Equipment	12.12	12.63	12.77	12.3	12.66	10.05
Long-Term Investments	-	0.1	0.1	3.6	3.6	3.6
Goodwill	191.13	122.74	118.9	117.71	115.81	18.19
Other Intangible Assets	71.74	1.12	2.1	2.52	1.97	2.29
Long-Term Deferred Charges	25.18	27.63	32.52	32.9	37.2	1.28
Other Long-Term Assets	3.83	0	0	-	-	0
Total Assets	430.57	256.76	257.17	316.33	330.73	209.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	23.35	20.87	19.02	16.82	18.53	16.77
Accrued Expenses	7.45	5.62	6.15	6.07	9.63	6.57
Current Portion of Long-Term Debt	-	-	-	13.28	13.73	3.68
Current Portion of Leases	-	-	-	1.8	1.6	1.56
Current Income Taxes Payable	5.82	5.5	5.48	3.56	1.97	6.28
Current Unearned Revenue	0.52	0.3	0.18	0.2	0.44	0.16
Other Current Liabilities	1.96	2.47	2.76	2.64	1.25	1.05
Total Current Liabilities	40.03	34.76	33.58	52.88	57.32	36.11
Long-Term Debt	9.01	10.12	9.77	81.23	94.34	7.01
Long-Term Leases	4.81	5.89	-	4.35	3.97	3.44
Pension & Post-Retirement Benefits	0.49	0.52	0.6	0.53	0.59	0.75
Long-Term Deferred Tax Liabilities	16.86	7.13	7.77	-	-	-
Other Long-Term Liabilities	167.97	14.42	26.59	2.17	1.53	1.69
Total Liabilities	239.17	72.83	78.31	141.16	157.75	49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.28	3.28	3.28	3.5	3.63	3.63
Additional Paid-In Capital	20.19	20.19	20.19	33.57	40.05	40.05
Comprehensive Income & Other	167.93	160.45	155.38	138.1	129.31	117.19
Total Common Equity	191.41	183.92	178.86	175.17	172.98	160.87
Shareholders' Equity	191.41	183.92	178.86	175.17	172.98	160.87
Total Liabilities & Equity	430.57	256.76	257.17	316.33	330.73	209.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.74	16	9.77	100.66	113.64	15.69
Net Cash (Debt)	11.6	4.66	13.3	-11.63	-27.7	86.7
Net Cash Growth	14.72%	-64.95%	-	-	-	141.89%
Net Cash Per Share	1.13	0.45	1.30	-1.04	-2.44	7.97
Filing Date Shares Outstanding	10.07	10.07	10.03	10.04	10.22	10.85
Total Common Shares Outstanding	10.07	10.07	10.03	10.04	10.22	10.85
Working Capital	86.55	56.82	56	91.03	91.37	137.49
Book Value Per Share	19.01	18.27	17.82	17.44	16.92	14.83
Tangible Book Value	-71.47	60.06	57.86	54.94	55.21	140.39
Tangible Book Value Per Share	-7.10	5.97	5.77	5.47	5.40	12.94
Buildings	2.89	1.86	1.82	1.33	0.88	0.85
Machinery	21.02	1.33	1.09	0.76	1.12	1.12
Construction In Progress	0.17	0.01	0.05	0.48	0.45	0.01

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error